CBD-Intel

Europe

This page contains all of our content that relates to Europe. This includes all of our full-length market and regulatory reports, all of our business and regulatory news coverage, and our many trackers, databases, and live alerts.

Visit our coverage on some of the top vaping countries we cover: United Kingdom, France, Italy, Germany

Europe is a major CBD market facing issues such as novel food regulation, debates over medical cannabis, and EU policy. We report on market, business and legal developments throughout Europe.

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation

Sign up to our newsletter

By signing up you agree to our Terms and Conditions